Department of Molecular Biology and Genetics, Istanbul Technical University, Istanbul, Turkey.
Human Genetics Program, Department of Zoology, Faculty of Biological Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Eur J Med Genet. 2021 Apr;64(4):104181. doi: 10.1016/j.ejmg.2021.104181. Epub 2021 Feb 27.
In a consanguineous Pakistani kinship afflicted with mild to moderate intellectual disability (ID), mild lissencephaly, brain atrophy and skeletal anomalies, we detected homozygous CRADD c.2T > G (p.Met1?) and USP44 c.873_886delinsT (p.Leu291Phefs*8), two good candidates 1.85-Mb apart that segregated with the disorder. Biallelic damaging variants in CRADD cause recessive mental retardation-34 (MRT34; MIM 614499) with mild to moderate ID, "thin" lissencephaly, and variable megalencephaly and seizures. For USP44, only a single ID family has been reported with a homozygous deleterious variant, which is the same as the variant we detected. In affected individuals we present, at ages 29-32 years, clinical findings are similar yet not fully concordant with phenotypes for either gene considering the skeletal findings, and ID is not as severe as would be expected for defects in two genes with additive effect. Some variable CRADD-related features such as language impairment and seizures are not observed in the presented family. The presence of the two variants in the family is a very rare example of familial linked homozygous variants, and whether the damaging USP44 variant contributed to the disease in the family we present is not clear. As for the skeletal findings, facial dysmorphism and digestive problems, we did not find a candidate variant. This study is an example of both clinical variation and difficulty in variant detection and evaluation. Our findings highlight that even an extensive exome sequence analysis can fail to fully uncover the complex molecular basis of a syndrome even if potentially causative variants are identified.
在一个患有轻度至中度智力障碍(ID)、轻度无脑回畸形、脑萎缩和骨骼异常的巴基斯坦血缘亲属中,我们检测到纯合 CRADD c.2T>G(p.Met1?)和 USP44 c.873_886delinsT(p.Leu291Phefs*8),这两个候选基因相距 1.85Mb,与疾病共分离。CRADD 中的双等位基因破坏性变异导致隐性智力障碍 34 型(MRT34;MIM 614499),具有轻度至中度 ID、“薄”无脑回畸形和可变巨脑和癫痫。对于 USP44,仅报道了一个 ID 家族存在纯合有害变异,与我们检测到的变异相同。在受影响的个体中,我们呈现的年龄为 29-32 岁,临床发现与任何一个基因的表型相似但不完全一致,考虑到骨骼发现,ID 并不像两个具有累加效应的基因缺陷所预期的那样严重。在呈现的家族中,没有观察到一些可变的 CRADD 相关特征,如语言障碍和癫痫。这两个变异在家族中的存在是家族性连锁纯合变异的非常罕见的例子,并且在我们呈现的家族中,破坏性 USP44 变异是否导致疾病尚不清楚。至于骨骼发现,面部畸形和消化问题,我们没有找到候选变异。本研究是临床变异和变异检测与评估困难的一个例子。我们的发现强调,即使进行了广泛的外显子组序列分析,也可能无法完全揭示综合征的复杂分子基础,即使潜在的致病变异已被确定。